By now, almost everyone has spoken to Alexa and Siri or asked for advice from the sage oracle, ChatGPT. Just like cell phones and the internet, artificial intelligence (AI) is increasingly a part of everyday life.

But what could it mean for the future of biomedicine and healthcare?

Our next mini symposium will explore this complex and critical topic, with special guest Peter Lee, Ph.D., President of Microsoft Research, one of the world’s leaders in AI medical science.

Dr. Lee leads research for Microsoft across 13 laboratories worldwide. He is a member of the National Academy of Medicine and under President Obama, he was a Commissioner on Enhancing National Cybersecurity. In 2023, he coauthored “The AI Revolution in Medicine, GPT-4 and Beyond” and was named by Time magazine in 2024 as one of the 100 most influential people in health and life sciences.

From all accounts, AI is poised to revolutionize numerous aspects of medical research and care. In fact, the change has already begun. With unparalleled speed and efficiency, this technology can plow through vast amounts of data in nanoseconds. From diagnostics and treatment planning to drug discovery and innovations we haven’t even imagined, AI is revolutionizing medical research and care.

On Sept. 11 at 2 p.m., via Zoom, Eva L. Feldman, M.D., Ph.D, will sit down with Dr. Lee for a discussion of “AI & the Future of Medicine.”

Dr. Feldman will then be joined by Michigan Medicine’s own AI experts — Michael Burns, M.D., Ph.D.; Brahmajee Nallamothu, M.D.; and Jenna Wiens, Ph.D. — for a live panel discussion during which they will field questions from the audience.